The Provincial Government of Trentino has approved a sweeping update to its diabetes care standards, expanding free access to real-time continuous glucose monitoring devices and eliminating out-of-pocket costs for essential retinal screenings, according to a regional policy announcement reported by La Digetto. Backed by regional health authorities, the new framework shifts public healthcare provisions away from older flash glucose monitoring technology and toward modern continuous systems designed to prevent acute medical emergencies among thousands of patients living with chronic metabolic conditions.
Diabetes remains a primary public health challenge across the Italian province. Official health statistics indicate that the condition impacts 5.8% of the local population—equating to approximately 32,000 people based on 2024 data—nested within a broader national framework of approximately 4 million patients. Type 2 diabetes accounts for 90% of all local diagnoses, driven increasingly by sedentary habits and rising rates of obesity among younger demographics, while type 1 diabetes and rarer specific forms comprise the remaining 10%.
Transitioning to Real-Time Continuous Glucose Monitoring
The newly enacted resolution completely replaces regional regulations that had been in place since 2021. Under the updated criteria, the Provincial Health Service will phase out older Flash Glucose Monitoring (FGM) tools in favor of advanced Continuous Glucose Monitoring (CGM) technology. Unlike older flash sensors, modern CGM units transmit real-time data continuously and feature built-in threshold or predictive alarms to warn users of dangerous glycemic swings.
Regional health data shows that approximately 2,200 patients across the province currently utilize continuous glucose sensors. The policy shift broadens eligibility beyond the previous threshold, which restricted free provision strictly to patients requiring three or more daily insulin injections. According to the policy announcement detailed by Agenzia Giornalistica Opinione, the updated criteria extend free device access to people with type 2 diabetes who require two or more daily administrations, patients relying solely on basal insulin under specific clinical indications, and individuals diagnosed with type 1 diabetes in early, pre-conclamatory stages.
“With this provvedimento aggiorniamo i criteri per la prescrizione e l’erogazione dei dispositivi di monitoraggio continuo del glucosio a carico del Servizio sanitario provinciale,” stated Mario Tonina, provincial assessor for health, social policies, and cooperation, as reported by La Digetto. “Ampliamo così l’accesso gratuito a nuove categorie di persone, con l’obiettivo di migliorare il controllo glicemico e ridurre il rischio di episodi acuti.”
Expanding Preventive Retinal Screenings
Alongside updated device distribution rules, the regional government has instituted a complete fee waiver for fundus photography examinations. This diagnostic imaging procedure serves as a screening tool for diabetic retinopathy. By eliminating cost barriers for regular fundus evaluations, health officials intend to catch ocular complications at an early stage.
Assessor Tonina emphasized the preventive impact of the measure, noting that guaranteeing free technological aids and diagnostic screening allows for a more personalized therapeutic management plan. Regional health planners anticipate that aligning local care protocols with the latest national and international scientific guidelines will improve long-term safety and overall quality of life for thousands of patients managing chronic care regimens across the province.
Implementation and Next Steps
Keep reading